Torren Management
CLPT icon

Torren Management’s ClearPoint Neuro CLPT Stock Holding History

Torren Management’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$440 Hold
36
– – ﹤0.01% 863
2026
Q2 		$642 Hold
36
– – ﹤0.01% 827
2026
Q1 		$328 Hold
36
– – ﹤0.01% 920
2025
Q4 		$492 Buy
+36
New +$667 ﹤0.01% 1336

Other funds holding CLPT

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pekin Hardy Strauss
Pekin Hardy Strauss Chicago, Illinois $1.14B AUM 25.53% 1-Year Est. Return
Compass Financial Management
Compass Financial Management Tampa, Florida $926M AUM
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Parsons Capital Management
Parsons Capital Management Providence, Rhode Island $2.29B AUM 21.99% 1-Year Est. Return
Taylor Frigon Capital Management
Taylor Frigon Capital Management Scottsdale, Arizona $197M AUM 35.01% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $483B AUM 41.26% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Torren Management's CLPT Position: Q3 2026 in Review

Torren Management held its ClearPoint Neuro (CLPT) position steady in Q3 2026 at 36 shares worth $440. The position accounts for ﹤0.01% of the portfolio, ranked #863.

Torren Management first reported a position in CLPT in Q4 2025 and has held it in 4 quarters since. The position peaked at $642 in Q2 2026. 45 funds tracked by Wall St. Rank hold CLPT as of Q3 2026.

  • Torren Management held 36 shares of ClearPoint Neuro worth $440 as of Q3 2026.
  • Torren Management left its ClearPoint Neuro share count unchanged in Q3 2026.
  • ClearPoint Neuro made up ﹤0.01% of Torren Management's portfolio in Q3 2026, its #863 holding.
  • Torren Management first reported a position in ClearPoint Neuro in Q4 2025 and has held it in 4 quarters since.
  • Torren Management's ClearPoint Neuro position peaked at $642 in Q2 2026.
  • 45 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q3 2026.

Based on Torren Management's 13F filing for Q3 2026, filed 29 Oct 2026.